These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19930232)
1. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. Baiardini I; Bousquet PJ; Brzoza Z; Canonica GW; Compalati E; Fiocchi A; Fokkens W; van Wijk RG; La Grutta S; Lombardi C; Maurer M; Pinto AM; Ridolo E; Senna GE; Terreehorst I; Bom AT; Bousquet J; Zuberbier T; Braido F; Allergy; 2010 Mar; 65(3):290-5. PubMed ID: 19930232 [TBL] [Abstract][Full Text] [Related]
2. Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. Braido F; Bousquet PJ; Brzoza Z; Canonica GW; Compalati E; Fiocchi A; Fokkens W; Gerth van Wijk R; La Grutta S; Lombardi C; Maurer M; Pinto AM; Ridolo E; Senna GE; Terreehorst I; Todo Bom A; Bousquet J; Zuberbier T; Baiardini I Allergy; 2010 Aug; 65(8):959-68. PubMed ID: 20486919 [TBL] [Abstract][Full Text] [Related]
3. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Baiardini I; Braido F; Bindslev-Jensen C; Bousquet PJ; Brzoza Z; Canonica GW; Compalati E; Fiocchi A; Fokkens W; Gerth van Wijk R; Giménez-Arnau A; Godse K; Grattan C; Grob JJ; La Grutta S; Kalogeromitros D; Kocatürk E; Lombardi C; Mota-Pinto A; Ridolo E; Saini SS; Sanchez-Borges M; Senna GE; Terreehorst I; Todo Bom A; Toubi E; Bousquet J; Zuberbier T; Maurer M Allergy; 2011 Jul; 66(7):840-4. PubMed ID: 21385184 [TBL] [Abstract][Full Text] [Related]
4. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. Wiklund I Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288 [TBL] [Abstract][Full Text] [Related]
5. How to anticipate the assessment of the public health benefit of new medicines? Massol J; Puech A; Boissel JP; Therapie; 2007; 62(5):427-35. PubMed ID: 18206104 [TBL] [Abstract][Full Text] [Related]
6. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
7. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Willke RJ; Burke LB; Erickson P Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741 [TBL] [Abstract][Full Text] [Related]
12. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
13. Translating the science of patient-reported outcomes assessment into clinical practice. Osoba D J Natl Cancer Inst Monogr; 2007; (37):5-11. PubMed ID: 17951224 [TBL] [Abstract][Full Text] [Related]
15. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. Garcia SF; Cella D; Clauser SB; Flynn KE; Lad T; Lai JS; Reeve BB; Smith AW; Stone AA; Weinfurt K J Clin Oncol; 2007 Nov; 25(32):5106-12. PubMed ID: 17991929 [TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000. McNaughton-Collins M; Walker-Corkery E; Barry MJ J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921 [TBL] [Abstract][Full Text] [Related]
17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
18. Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels. Gondek K; Sagnier PP; Gilchrist K; Woolley JM J Clin Oncol; 2007 Nov; 25(32):5087-93. PubMed ID: 17991926 [TBL] [Abstract][Full Text] [Related]
19. Measurement and analysis of patient-reported outcomes. Meyer KB; Clayton KA Methods Mol Biol; 2009; 473():155-69. PubMed ID: 19160737 [TBL] [Abstract][Full Text] [Related]
20. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]